NIH privatization under fire

Congressional Democrats warn of outsourcing plan's effect on science, security, and morale

Written byMerrill Goozner
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The National Institutes of Health (NIH) plan to put thousands of scientific support jobs up for bid by outside contractors drew fire this week from agency watchdogs.

In a letter sent to Joshua Bolten, director of the Office of Management and Budget, and Tommy Thompson, secretary of Health and Human Services, Rep. Henry Waxman (D-Calif.) and the Maryland congressional delegation complained that the outsourcing plan would put NIH at risk because it "meddles with scientists, opens the door to unnecessary security threats, and seriously undermines morale and productivity."

The NIH effort is part of the Bush administration's effort to privatize as much government work as possible. Over the next few years, outsourcing could affect as many as 4600 jobs on the sprawling 327-acre NIH campus in Bethesda, Md., just outside the US capital.

Today (October 22), NIH will announce whether an outside firm or current employees will provide real estate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies